Straits Times Index
3,272.72 +47.55 (+1.47%) S&P 500
5,061.29 +50.69 (+1.01%) Dow
38,455.48 +215.50 (+0.56%) Nasdaq
15,659.98 +208.68 (+1.35%) Bitcoin USD
66,948.84 +854.13 (+1.29%) CMC Crypto 200
1,436.26 +21.50 (+1.52%)
Anavex Life Sciences Corp. (AVXL)
| Previous close | 3.6800 |
| Open | 3.6900 |
| Bid | 3.8300 x 600 |
| Ask | 3.8600 x 100 |
| Day's range | 3.6900 - 3.9100 |
| 52-week range | 3.6000 - 10.4500 |
| Volume | |
| Avg. volume | 1,286,280 |
| Market cap | 316.544M |
| Beta (5Y monthly) | 0.57 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Insider Monkey
12 $10 Stocks That Will Triple
In this article, we discuss 12 $10 stocks that will triple. If you want to skip our discussion on the latest stock market landscape, head over to 5 $10 Stocks That Will Triple. According to JPMorgan, the global outlook for securities markets in 2024 suggests a more positive scenario compared to the previous year, with […]
- Insider Monkey
Anavex Life Sciences Corp. (NASDAQ:AVXL) Q1 2024 Earnings Call Transcript
Anavex Life Sciences Corp. (NASDAQ:AVXL) Q1 2024 Earnings Call Transcript February 7, 2024 Anavex Life Sciences Corp. beats earnings expectations. Reported EPS is $-0.0001, expectations were $-0.14. AVXL isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning. Welcome to […]
- Zacks
Vertex's (VRTX) Non-Opioid Pain Drug Meets Primary Goal
Three late-stage studies data show that Vertex's (VRTX) experimental non-opioid drug reduced pain across a 48-hour period. Based on this data, VRTX intends to submit an FDA filing by mid-2024.
